‘This isn’t just semantics’

Opinion, comment and editorials of the day

Vials of the mpox virus are seen in a photo from Ankara, Turkey.
The ‘modernized name, mpox, offered something rare in a health crisis’
(Image credit: Hakan Nural / Anadolu / Getty Images)

‘Why HHS is wrong to bring back the stigmatizing monkeypox name’

Nikki Romanik and Demetre Daskalakis at Time

The monkeypox name “carried stigma and confusion, making people less likely to get vaccinated, tested or seek treatment,” say Nikki Romanik and Demetre Daskalakis. The “modernized name, mpox, offered something rare in a health crisis — clarity and dignity for those over-represented in the outbreak.” HHS has “conveyed its intent to return to the old name, ‘monkeypox,’” but this “name was more than inaccurate, it was one of the foundational barriers to stopping the outbreak.”

Read more

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

‘Insurers use cancer patients as leverage’

Selwyn M. Vickers and Scott M. Stuart and The Wall Street Journal

Despite “record profits, major insurers are using the threat of network termination as a bargaining chip in contract disputes with providers,” say Selwyn M. Vickers and Scott M. Stuart. The “negotiation tactic puts patients in the middle of corporate standoffs during serious, often life-threatening, illnesses.” Insurers “respond not with good-faith engagement but with delay tactics, public attacks and abrupt notices that force thousands of cancer patients to worry that they could soon lose access to their doctor.”

Read more

‘“The Smashing Machine” is Dwayne Johnson’s big Oscar play, but it’s no typical biopic’

Dana Stevens at Slate

“‘The Smashing Machine’ deliberately sets out to subvert the expectations of audiences,” says Dana Stevens. It’s a “study of a flawed but admirably dedicated athlete.” The film is a “showcase for its star Dwayne Johnson, whose own history as a pro wrestler is an inextricable part of the screen persona he’s created.” But the film “winds up playing its cards too close to the vest, never really giving the star, or the movie, a chance to strut his stuff.”

Read more

‘Why Trump’s 20-point plan for ending the Gaza war simply won’t work’

Michael Ratney at Haaretz

Donald Trump’s “20-point plan for the end of the Gaza war includes some positive aspects,” but “none of the comments made by President Trump or Prime Minister Netanyahu on Monday should suggest that the plan will actually be implemented,” says Michael Ratney. And they “certainly shouldn’t be seen as a fundamental shift in the trajectory of the Israeli-Palestinian conflict.” The deal is “decidedly unpalatable to other, critically important partners in this process: regional governments in the Middle East.”

Read more

Justin Klawans, The Week US

Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.